Statins and progressive renal disease

Medicinal Research Reviews

Volumn 22, Issue 1, 2002, Pages 76-84

  Buemi, Michele ^a,b   Senatore, Massimino ^a   Corica, Francesco ^a   Aloisi, Carmela ^a   Romeo, Adolfo ^a   Cavallaro, Emanuela ^a   Floccari, Fulvio ^a   Tramontana, Domenico ^a   Frisina, Nicola ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b NONE   (Italy)

Author keywords

Apoptosis; Chemokines; HMG CoA reductase inhibitors; IgA; Nephropathy; Prenylation

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT; STATIN;

APOPTOSIS; DRUG EFFECT; DRUG MECHANISM; HUMAN; IMMUNOREGULATION; KIDNEY DISEASE; LIPID BLOOD LEVEL; REVIEW;

ADULT; ANTICHOLESTEREMIC AGENTS; APOPTOSIS; ARTERIOSCLEROSIS; CELL DIVISION; CHEMOKINES; DISEASE PROGRESSION; FEMALE; HUMANS; KIDNEY; KIDNEY DISEASES; MALE; MIDDLE AGED; SIGNAL TRANSDUCTION; UREMIA;

EID: 0036138105     PISSN: 01986325     EISSN: None     Source Type: Journal    
DOI: 10.1002/med.10000     Document Type: Review

References (42)

1. USRDS 1999 annual data report
2. Accelerated atherosclerosis in prolonged maintenance hemodialysis
3. Dyslipidemia in renal disease
4. Drug treatment of lipid disorders
5. Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease
6. Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats
7. Effects of lipids on the pathogenesis of progressive renal failure: Role of 3-hydroxy-3-methylglutaryl co-enzyme A reductase inhibitors in the prevention of glomerulosclerosis
8. Human mesangial cell production of monocyte chemoattractant protein-1: Modulation by lovastatin
9. Simvastatin inhibits PDGF-induced DNA synthesis in human glomerular mesangial cells
10. Cardiovascular remodelling, apoptosis and drugs
11. Relation of cholesterol and mevalonic acid to the cell cycle in smooth muscle and Swiss 3T3 cells stimulated to divide by platelet-derived growth factor
12. Oxidative modification of low-density lipoproteins by mesangial cells
13. Effects of lipoproteins on cultured human mesangial cells
14. Inhibition of cultured vascular smooth muscle cell migration by simvastatin (MK-733)
15. Inhibition of proliferation of arterial smooth muscle cells by fluvastatin
16. Inhibition of human vascular smooth muscle cell proliferation by lovastatin: The role of isoprenoid intermediates of cholesterol synthesis
17. Essential role for mevalonate synthesis in DNA replication
18. Regulation of the mevalonate pathway
19. Geranylgeranylated rho small GTPase are essential for the degradation of p27kip1 and facilitate the progression from G1 to S phase in growth-stimulated rat FRTL-5 cells
20. Lovastatin-induced inhibition of renal epithelial tubular cell proliferation involves a p21ras activated, AP-1-dependent pathway
21. Effects of fuvastatin on growth of porcine and human vascular smooth muscle cells in vitro
22. Lovastatin inhibits proliferation of rat mesangial cells
23. Proapoptotic effect of fluvastatin on human smooth muscle cells
24. HMG-CoA reductase inhibitors and apoptosis
25. 3-Hydroxy-3-methylglutaril coenzyme A reductase and isoprenylation inhibitors induce apoptosis of vascular smooth muscle cells in culture
26. Lovastatin induces apoptosis by inhibiting mitotic and postmitotic events in cultured mesangial cells
27. Effects of lisinopril administration on blood bcl-2 concentrations in patients with immunoglobulin A nephropathy
28. Apoptosis and the kidney
29. The role of altered metabolism in the progression of renal disease: Experimental evidence
30. Human mesangial cell production of monocyte chemoattractant protein-1: Modulation by lovastatin
31. Up-regulation of macrophage colony-stimulating factor (M-CSF) and migration inhibitory factor (MIF) expression and monocyte recruitment during lipid-induced glomerular injury in the exogenous hypercholesterolemic (ExHC) rat
32. kB activation in human mesangial cells
33. Effect of fluvastatin on proteinuria in patients with IgA nephropathy
34. Recent advances in statins and the kidney
35. Cytokines, growth factors and renal injury: Where do we go now?
36. Cell cycle: Routine role for Ras
37. Farnesylated g-subunit of photoreceptor G protein indispensable for GTP-binding
38. Ras isoprenylation is required for ras-induced but not for NGF-induced neuronal differentiation of PC12 Cells
39. New insight into the interaction of Ras with the plasma membrane
40. Tumour resistance to oxidative stress: Association with ras oncogene expression and reversal by lovastatin, an inhibitor of p21-ras isoprenylation
41. Lovastatin, a cholesterol biosynthesis inhibitor, inhibits growth of human H-ras oncogene transformed cells in nude mice
42. Lipophilic statins induce apoptosis of human vascular smooth muscle cells